Xeris Biopharma Holdings, Inc. · NASDAQ:XERS
Hecht Beth sold 16,667 Xeris Biopharma Holdings, Inc. shares (Form 4)
Traded Apr 1, 2026 · Filed Apr 3, 2026
On Apr 1, 2026, Hecht Beth (See Remarks) sold 16,667 Xeris Biopharma Holdings, Inc. shares at US$5.99 for US$99,835 under a trading plan, leaving 1,209,840 shares. Filed Apr 3, 2026 (Form 4).
- Sold
- 16,667 shares
- Price
- US$5.99
- Value
- US$99,835
- Holding after
- 1,209,840 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | Sale | 16,667 | US$5.99 | 1,209,840 | Direct |
Source
Related
- Xeris Biopharma Holdings, Inc.
- Hecht Beth
- Xeris Biopharma Holdings, Inc. shareholders
- Form 4 · Hecht Beth · Oct 2, 2026
- Form 4 · Hecht Beth · Sep 1, 2026
- Form 4 · Hecht Beth · Aug 4, 2026
- Form 4 · Hecht Beth · Jul 2, 2026
- Form 4 · Hecht Beth · Jun 2, 2026
- Form 4 · McCulloch Kevin · Oct 2, 2026
- Form 4 · Pieper Steven · Oct 2, 2026
- Form 4 · McCulloch Kevin · Sep 29, 2026
- Form 4 · McCulloch Kevin · Sep 1, 2026
- Form 4 · Pieper Steven · Sep 1, 2026